Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 28

1.

Electronic cigarette vapour increases virulence and inflammatory potential of respiratory pathogens.

Gilpin DF, McGown KA, Gallagher K, Bengoechea J, Dumigan A, Einarsson G, Elborn JS, Tunney MM.

Respir Res. 2019 Dec 18;20(1):267. doi: 10.1186/s12931-019-1206-8.

2.

Influence of azithromycin and allograft rejection on the post-lung transplant microbiota.

Spence CD, Vanaudenaerde B, Einarsson GG, Mcdonough J, Lee AJ, Johnston E, Verleden GM, Elborn JS, Dupont LJ, Van Herck A, Gilpin DF, Vos R, Tunney MM, Verleden SE.

J Heart Lung Transplant. 2020 Feb;39(2):176-183. doi: 10.1016/j.healun.2019.11.007. Epub 2019 Nov 21.

PMID:
31812487
3.

Susceptibility of Pseudomonas aeruginosa Recovered from Cystic Fibrosis Patients to Murepavadin and 13 Comparator Antibiotics.

Ekkelenkamp MB, Cantón R, Díez-Aguilar M, Tunney MM, Gilpin DF, Bernardini F, Dale GE, Elborn JS, Bayjanov JR, Fluit A.

Antimicrob Agents Chemother. 2020 Jan 27;64(2). pii: e01541-19. doi: 10.1128/AAC.01541-19. Print 2020 Jan 27.

PMID:
31767727
4.

Assessment of stability and fluctuations of cultured lower airway bacterial communities in people with cystic fibrosis.

Sherrard LJ, Einarsson GG, Johnston E, O'Neill K, McIlreavey L, McGrath SJ, Gilpin DF, Downey DG, Reid A, McElvaney NG, Boucher RC, Muhlebach MS, Elborn JS, Tunney MM.

J Cyst Fibros. 2019 Nov;18(6):808-816. doi: 10.1016/j.jcf.2019.02.012. Epub 2019 Mar 21.

PMID:
30905581
5.

Mechanisms of reduced susceptibility and genotypic prediction of antibiotic resistance in Prevotella isolated from cystic fibrosis (CF) and non-CF patients.

Sherrard LJ, Schaible B, Graham KA, McGrath SJ, McIlreavey L, Hatch J, Wolfgang MC, Muhlebach MS, Gilpin DF, Schneiders T, Stuart Elborn J, Tunney MM.

J Antimicrob Chemother. 2018 Nov 1;73(11):3218. doi: 10.1093/jac/dky313. No abstract available.

6.

Activity of hypothiocyanite and lactoferrin (ALX-009) against respiratory cystic fibrosis pathogens in sputum.

Tunney MM, Payne JE, McGrath SJ, Einarsson GG, Ingram RJ, Gilpin DF, Juarez-Perez V, Elborn JS.

J Antimicrob Chemother. 2018 Dec 1;73(12):3391-3397. doi: 10.1093/jac/dky357.

PMID:
30219825
7.

Criteria required for an acceptable point-of-care test for UTI detection: Obtaining consensus using the Delphi technique.

Weir NM, Pattison SH, Kearney P, Stafford B, Gormley GJ, Crockard MA, Gilpin DF, Tunney MM, Hughes CM.

PLoS One. 2018 Jun 7;13(6):e0198595. doi: 10.1371/journal.pone.0198595. eCollection 2018.

8.

Evidence of persistence of Prevotella spp. in the cystic fibrosis lung.

Gilpin DF, Nixon KA, Bull M, McGrath SJ, Sherrard L, Rolain JM, Mahenthiralingam E, Elborn JS, Tunney MM.

J Med Microbiol. 2017 Jun;66(6):825-832. doi: 10.1099/jmm.0.000500.

PMID:
28604331
9.

Antibiotic susceptibility of planktonic- and biofilm-grown staphylococci isolated from implant-associated infections: should MBEC and nature of biofilm formation replace MIC?

Brady AJ, Laverty G, Gilpin DF, Kearney P, Tunney M.

J Med Microbiol. 2017 Apr;66(4):461-469. doi: 10.1099/jmm.0.000466.

PMID:
28463662
10.

Corrigendum to 'Efficacy of a standard meticillin-resistant Staphylococcus aureus decolonisation protocol in routine clinical practice' [Journal of Hospital Infection (2010) 93-98].

Gilpin DF, Small S, Bakshi S, Kearney MP, Cardwell C, Tunney MM.

J Hosp Infect. 2016 Dec;94(4):411. doi: 10.1016/j.jhin.2016.07.018. Epub 2016 Oct 19. No abstract available.

PMID:
27771148
11.

Production of extended-spectrum β-lactamases and the potential indirect pathogenic role of Prevotella isolates from the cystic fibrosis respiratory microbiota.

Sherrard LJ, McGrath SJ, McIlreavey L, Hatch J, Wolfgang MC, Muhlebach MS, Gilpin DF, Elborn JS, Tunney MM.

Int J Antimicrob Agents. 2016 Feb;47(2):140-5. doi: 10.1016/j.ijantimicag.2015.12.004. Epub 2015 Dec 29.

12.

Mechanisms of reduced susceptibility and genotypic prediction of antibiotic resistance in Prevotella isolated from cystic fibrosis (CF) and non-CF patients.

Sherrard LJ, Schaible B, Graham KA, McGrath SJ, McIlreavey L, Hatch J, Wolfgang MC, Muhlebach MS, Gilpin DF, Schneiders T, Elborn JS, Tunney MM.

J Antimicrob Chemother. 2014 Oct;69(10):2690-8. doi: 10.1093/jac/dku192. Epub 2014 Jun 10. Erratum in: J Antimicrob Chemother. 2018 Nov 1;73(11):3218.

13.

The future of antimicrobial therapy in the era of antibiotic resistance in cystic fibrosis pulmonary infection.

McCaughey G, Gilpin D, Elborn J, Tunney MM.

Expert Rev Respir Med. 2013 Aug;7(4):385-96. doi: 10.1586/17476348.2013.814411. Review.

PMID:
23964628
14.

Fosfomycin and tobramycin in combination downregulate nitrate reductase genes narG and narH, resulting in increased activity against Pseudomonas aeruginosa under anaerobic conditions.

McCaughey G, Gilpin DF, Schneiders T, Hoffman LR, McKevitt M, Elborn JS, Tunney MM.

Antimicrob Agents Chemother. 2013 Nov;57(11):5406-14. doi: 10.1128/AAC.00750-13. Epub 2013 Aug 19.

15.

Antibiotic resistance in Prevotella species isolated from patients with cystic fibrosis.

Sherrard LJ, Graham KA, McGrath SJ, McIlreavey L, Hatch J, Muhlebach MS, Wolfgang MC, Gilpin DF, Elborn JS, Schneiders T, Tunney MM.

J Antimicrob Chemother. 2013 Oct;68(10):2369-74. doi: 10.1093/jac/dkt191. Epub 2013 May 21.

16.

The adult cystic fibrosis airway microbiota is stable over time and infection type, and highly resilient to antibiotic treatment of exacerbations.

Fodor AA, Klem ER, Gilpin DF, Elborn JS, Boucher RC, Tunney MM, Wolfgang MC.

PLoS One. 2012;7(9):e45001. doi: 10.1371/journal.pone.0045001. Epub 2012 Sep 26.

17.

Use of culture and molecular analysis to determine the effect of antibiotic treatment on microbial community diversity and abundance during exacerbation in patients with cystic fibrosis.

Tunney MM, Klem ER, Fodor AA, Gilpin DF, Moriarty TF, McGrath SJ, Muhlebach MS, Boucher RC, Cardwell C, Doering G, Elborn JS, Wolfgang MC.

Thorax. 2011 Jul;66(7):579-84. doi: 10.1136/thx.2010.137281. Epub 2011 Jan 26.

PMID:
21270069
18.

Cluster randomised controlled trial of an infection control education and training intervention programme focusing on meticillin-resistant Staphylococcus aureus in nursing homes for older people.

Baldwin NS, Gilpin DF, Tunney MM, Kearney MP, Crymble L, Cardwell C, Hughes CM.

J Hosp Infect. 2010 Sep;76(1):36-41. doi: 10.1016/j.jhin.2010.03.006. Epub 2010 May 7.

PMID:
20451294
19.

Efficacy of a standard methicillin-resistant Staphylococcus aureus decolonisation protocol in routine clinical practice.

Gilpin DF, Small S, Bakshi S, Kearney MP, Cardwell C, Tunney MM.

J Hosp Infect. 2010 Jun;75(2):93-8. doi: 10.1016/j.jhin.2009.11.025. Epub 2010 Mar 17. Erratum in: J Hosp Infect. 2016 Dec;94(4):410. [Corrected to: Bakshi S]. J Hosp Infect. 2016 Dec;94(4):411.

PMID:
20299134
20.

Treatment of a cochlear implant biofilm infection: a potential role for alternative antimicrobial agents.

Brady AJ, Farnan TB, Toner JG, Gilpin DF, Tunney MM.

J Laryngol Otol. 2010 Jul;124(7):729-38. doi: 10.1017/S0022215110000319. Epub 2010 Mar 10.

PMID:
20214837
21.

Prevalence of methicillin-resistant Staphylococcus aureus colonization in residents and staff in nursing homes in Northern Ireland.

Baldwin NS, Gilpin DF, Hughes CM, Kearney MP, Gardiner DA, Cardwell C, Tunney MM.

J Am Geriatr Soc. 2009 Apr;57(4):620-6. doi: 10.1111/j.1532-5415.2009.02181.x.

PMID:
19392953
22.

Can the use of a rapid polymerase chain screening method decrease the incidence of nosocomial meticillin-resistant Staphylococcus aureus?

Aldeyab MA, Kearney MP, Hughes CM, Scott MG, Tunney MM, Gilpin DF, Devine MJ, Watson JD, Gardiner A, Funston C, Savage K, McElnay JC.

J Hosp Infect. 2009 Jan;71(1):22-8. doi: 10.1016/j.jhin.2008.10.011. Epub 2008 Nov 26.

PMID:
19036472
23.

Changes in antibiotic susceptibility in staphylococci habituated to sub-lethal concentrations of tea tree oil (Melaleuca alternifolia).

McMahon MA, Tunney MM, Moore JE, Blair IS, Gilpin DF, McDowell DA.

Lett Appl Microbiol. 2008 Oct;47(4):263-8. doi: 10.1111/j.1472-765X.2008.02420.x.

24.

Detection of anaerobic bacteria in high numbers in sputum from patients with cystic fibrosis.

Tunney MM, Field TR, Moriarty TF, Patrick S, Doering G, Muhlebach MS, Wolfgang MC, Boucher R, Gilpin DF, McDowell A, Elborn JS.

Am J Respir Crit Care Med. 2008 May 1;177(9):995-1001. doi: 10.1164/rccm.200708-1151OC. Epub 2008 Feb 8.

PMID:
18263800
25.

T lymphocyte epitope mapping of porcine circovirus type 2.

Stevenson LS, Gilpin DF, Douglas A, McNeilly F, McNair I, Adair BM, Allan GM.

Viral Immunol. 2007 Sep;20(3):389-98.

PMID:
17931109
26.

Rapid detection of MRSA in a routine diagnostic laboratory using a real-time PCR assay.

Gilpin DF, Tunney MM, Funston C, Savage K, Gardiner A, Kearney MP.

J Hosp Infect. 2007 Sep;67(1):97-9. Epub 2007 Aug 27. No abstract available.

PMID:
17719687
27.

Cytokine and C-reactive protein profiles induced by porcine circovirus type 2 experimental infection in 3-week-old piglets.

Stevenson LS, McCullough K, Vincent I, Gilpin DF, Summerfield A, Nielsen J, McNeilly F, Adair BM, Allan GM.

Viral Immunol. 2006 Summer;19(2):189-95.

PMID:
16817761
28.

In vitro studies on the infection and replication of porcine circovirus type 2 in cells of the porcine immune system.

Gilpin DF, McCullough K, Meehan BM, McNeilly F, McNair I, Stevenson LS, Foster JC, Ellis JA, Krakowka S, Adair BM, Allan GM.

Vet Immunol Immunopathol. 2003 Aug 15;94(3-4):149-61.

PMID:
12909411

Supplemental Content

Loading ...
Support Center